Capital Management Associates NY bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 6,000 shares of the exchange traded fund’s stock, valued at approximately $732,000.
A number of other large investors have also recently bought and sold shares of XBI. Legacy Wealth Managment LLC ID acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $32,000. Ballast Advisors LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $36,000. Creative Financial Designs Inc. ADV acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $39,000. Barnes Dennig Private Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $48,000. Finally, Navalign LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $48,000.
SPDR S&P Biotech ETF Price Performance
XBI stock opened at $131.66 on Tuesday. SPDR S&P Biotech ETF has a 52-week low of $78.00 and a 52-week high of $139.19. The stock’s fifty day simple moving average is $130.00 and its 200-day simple moving average is $125.32. The stock has a market capitalization of $8.40 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
